Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 31

1.

Lipoprotein apheresis reduces biomarkers of plaque destabilization and cardiovascular risk.

Strauchmann J, Wallbach M, Bramlage C, Puls M, Konstantinides S, Mueller GA, Koziolek MJ.

J Clin Apher. 2013 Nov 27. doi: 10.1002/jca.21311. [Epub ahead of print]

PMID:
24281903
[PubMed - as supplied by publisher]
2.

Improvement of renal graft function after conversion from a calcineurin inhibitor including immunosuppression to a mycophenolate sodium including regimen: a 4-year follow-up.

Heeg MH, Mueller GA, Bramlage C, Homayounfar K, Muehlhausen J, Leha A, Koziolek MJ.

Transplant Proc. 2013 Jan-Feb;45(1):142-7. doi: 10.1016/j.transproceed.2012.10.028.

PMID:
23375288
[PubMed - indexed for MEDLINE]
3.

Cellulose membranes are more effective in holding back vital proteins and exhibit less interaction with plasma proteins during hemodialysis.

Pešić I, Müller GA, Baumann C, Dihazi GH, Koziolek MJ, Eltoweissy M, Bramlage C, Asif AR, Dihazi H.

Biochim Biophys Acta. 2013 Apr;1834(4):754-62. doi: 10.1016/j.bbapap.2013.01.021. Epub 2013 Jan 28.

PMID:
23369790
[PubMed - indexed for MEDLINE]
Free Article
4.

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.

Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellström B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Grönhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R; SHARP Investigators.

Lancet. 2011 Jun 25;377(9784):2181-92. doi: 10.1016/S0140-6736(11)60739-3. Epub 2011 Jun 12.

PMID:
21663949
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

The role of bone morphogenetic protein-5 (BMP-5) in human nephrosclerosis.

Bramlage CP, Müller GA, Tampe B, Bevanda J, Maatouk I, Koziolek M, Lange K, Ahrens K, Schmid H, Cohen CD, Bramlage P, Kretzler M, Strutz F.

J Nephrol. 2011 Sep-Oct;24(5):647-55. doi: 10.5301/JN.2011.6330.

PMID:
21319131
[PubMed - indexed for MEDLINE]
6.

[Renal artery stenosis: angioplasty or drug treatment?].

Bramlage C, Cuneo A, Härtel D, Jung K, Witteck CH, Högel R, Müller GA, Bramlage P, Tebbe U; gleichberechtigte Erstautorenschaft.

Dtsch Med Wochenschr. 2011 Jan;136(3):76-81. doi: 10.1055/s-0030-1269442. Epub 2011 Jan 11. German.

PMID:
21225553
[PubMed - indexed for MEDLINE]
7.

Infliximab as therapeutic option in steroid-refractory ulcerative colitis after kidney transplantation: case report.

Temme J, Koziolek M, Bramlage C, Schaefer IM, Füzesi L, Ramadori G, Müller GA, Schwörer H.

Transplant Proc. 2010 Nov;42(9):3880-2. doi: 10.1016/j.transproceed.2010.08.044.

PMID:
21094876
[PubMed - indexed for MEDLINE]
8.

Bone morphogenetic protein (BMP)-7 expression is decreased in human hypertensive nephrosclerosis.

Bramlage CP, Tampe B, Koziolek M, Maatouk I, Bevanda J, Bramlage P, Ahrens K, Lange K, Schmid H, Cohen CD, Kretzler M, Müller GA.

BMC Nephrol. 2010 Nov 16;11:31. doi: 10.1186/1471-2369-11-31.

PMID:
21080950
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Retrospective analysis of long-term lipid apheresis at a single center.

Koziolek MJ, Hennig U, Zapf A, Bramlage C, Grupp C, Armstrong VW, Strutz F, Müller GA.

Ther Apher Dial. 2010 Apr;14(2):143-52. doi: 10.1111/j.1744-9987.2009.00747.x.

PMID:
20438535
[PubMed - indexed for MEDLINE]
10.

Low-density lipoprotein apheresis decreases ferritin, transferrin and vitamin B12, which may cause anemia in serially treated patients.

Bramlage CP, Armstrong VW, Zapf A, Bramlage P, Mueller GA, Koziolek MJ.

Ther Apher Dial. 2010 Apr;14(2):136-42. doi: 10.1111/j.1744-9987.2009.00715.x.

PMID:
20438534
[PubMed - indexed for MEDLINE]
11.

Role of CX3C-chemokine CX3C-L/fractalkine expression in a model of slowly progressive renal failure.

Koziolek MJ, Müller GA, Zapf A, Patschan D, Schmid H, Cohen CD, Koschnick S, Vasko R, Bramlage C, Strutz F.

Nephrol Dial Transplant. 2010 Mar;25(3):684-98. doi: 10.1093/ndt/gfp602. Epub 2009 Nov 24.

PMID:
19934081
[PubMed - indexed for MEDLINE]
Free Article
12.

Predictors of complications in therapeutic plasma exchange.

Bramlage CP, Schröder K, Bramlage P, Ahrens K, Zapf A, Müller GA, Koziolek MJ.

J Clin Apher. 2009;24(6):225-31. doi: 10.1002/jca.20217.

PMID:
19890911
[PubMed - indexed for MEDLINE]
13.

The CX(3)C-chemokine fractalkine in kidney diseases.

Koziolek MJ, Vasko R, Bramlage C, Müller GA, Strutz F.

Mini Rev Med Chem. 2009 Sep;9(10):1215-28. Review.

PMID:
19817712
[PubMed - indexed for MEDLINE]
14.

Prenatal dexamethasone exposure does not alter blood pressure and nephron number in the young adult marmoset monkey.

Bramlage CP, Schlumbohm C, Pryce CR, Mirza S, Schnell C, Amann K, Amstrong VW, Eitner F, Zapf A, Feldon J, Oellerich M, Fuchs E, Müller GA, Strutz F.

Hypertension. 2009 Nov;54(5):1115-22. doi: 10.1161/HYPERTENSIONAHA.109.136580. Epub 2009 Sep 21.

PMID:
19770406
[PubMed - indexed for MEDLINE]
Free Article
15.

[Microalbuminuria and albuminuria: differential diagnosis and consequences for treatment].

Koziolek MJ, Bramlage CP, Vasko R, Grupp C, Müller GA.

Dtsch Med Wochenschr. 2009 Aug;134(34-35):1681-5. doi: 10.1055/s-0029-1234000. Epub 2009 Aug 25. Review. German.

PMID:
19707964
[PubMed - indexed for MEDLINE]
16.

Modulatory effects of inflammation and therapy on GDF-5 expression in rheumatoid arthritis synovium.

Bramlage CP, Kaps C, Ungethüm U, Bramlage P, Koziolek M, Wessels J, Krenn V, Pruss A, Müller GA, Strutz F, Burmester GR, Häupl T.

Scand J Rheumatol. 2008 Nov-Dec;37(6):401-9. doi: 10.1080/03009740802120010.

PMID:
18830904
[PubMed - indexed for MEDLINE]
17.

[Progressive renal failure in spontaneous-onset cholesterol crystal embolism].

Neuhoff R, Bramlage C, Gröne E, Strutz F, Koziolek M, Müller GA.

Med Klin (Munich). 2008 Aug 15;103(8):598-601. doi: 10.1007/s00063-008-1096-x. Epub 2008 Sep 21. German.

PMID:
18807234
[PubMed - indexed for MEDLINE]
18.

[Prevention of cardiovascular disease by blocking the endocannabinoid system].

Bramlage P, Schindler C, Thoenes M, Bramlage CP, Böcking W, Kirch W.

Herz. 2007 Oct;32(7):560-7. Review. German.

PMID:
17972029
[PubMed - indexed for MEDLINE]
19.

[Albuminuria: an indicator of cardiovascular risk].

Bramlage P, Thoenes M, Paar WD, Bramlage CP, Schmieder RE.

Med Klin (Munich). 2007 Oct 15;102(10):833-43; quiz 844-5. German.

PMID:
17928967
[PubMed - indexed for MEDLINE]
20.

[Recent examples for drug (developments) in primary, secondary and tertiary prevention].

Bramlage P, Schindler C, Schmidt AC, Bramlage CP, Kirch W.

Dtsch Med Wochenschr. 2007 Oct;132(42):2212-6. Review. German.

PMID:
17926249
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk